Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:59 AM
Ignite Modification Date:
2025-12-26 @ 10:59 AM
NCT ID:
NCT04303806
Eligibility Criteria:
Inclusion Criteria:
* Age: 20-35 years.
* Singleton nonanomalous pregnancy (confirmed with an ultrasound examination).
* Normal lipid profile and normal liver transaminases.
* WBCs (4-11\*103/mm3).
* CRP \< 3 mg/L.
Exclusion Criteria:
* Parturient's refusal.
* Women with history of cardiac, respiratory, renal, neurologic or endocrine diseases.
* Contraindications for statin therapy (eg, hypersensitivity to rosuvastatin, recent or active liver disease).
* Concomitant therapy with fibrates, niacin, cyclosporine, clarithromycin, or erythromycin.
* Inability to tolerate oral medications secondary to severe nausea and vomiting of pregnancy.
* Multifetal gestation or fetal demise.
* Fetal abnormalities.
* Emergency surgeries.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
35 Years
Study:
NCT04303806
Study Brief:
Protocol Section:
NCT04303806